CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review.

Liu C, Fu X, Wang F, Ni W, Li R, Gao Z.

Open source

DOI
10.21037/jtd-2026-1560
Published
2026-08-17
Container
J Thorac Dis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/jtd-2026-1560,
  title = {CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review.},
  author = {Liu C and  Fu X and  Wang F and  Ni W and  Li R and  Gao Z.},
  year = {2026},
  journal = {J Thorac Dis},
  doi = {10.21037/jtd-2026-1560},
  url = {https://doi.org/10.21037/jtd-2026-1560}
}

RIS

TY  - JOUR
TI  - CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review.
AU  - Liu C
AU  -  Fu X
AU  -  Wang F
AU  -  Ni W
AU  -  Li R
AU  -  Gao Z.
PY  - 2026
JO  - J Thorac Dis
DO  - 10.21037/jtd-2026-1560
UR  - https://doi.org/10.21037/jtd-2026-1560
ER  - 

APA

C, L., X, F., F, W., W, N., R, L., & Z., G. (2026). CDK4/6 inhibitor-related interstitial lung disease in breast cancer: a single-center case series and literature-based patient-level review.. J Thorac Dis. https://doi.org/10.21037/jtd-2026-1560

Source records